SHFHOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Scientist Home Future Health Ltd
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.70+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $40.32M
- P/E (TTM)
- –
- Dividend yield
- –
Scientist Home Future Health Ltd revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | % of revenue |
|---|---|---|---|---|
| Others (Delivery Fee) | $175.87K | $138.22K | $47.81K | 44.0% |
| Scientist Home Mixed Gelatine Hydrolysate | $49.01K | $53.87K | $60.45K | 12.3% |
| Scientist Home High Concentration Proteinase | – | – | $43.75K | – |
| Scientist Home Vein Cream | – | – | $22.63K | – |
| Scientist Home Bone Gelatine Hydrolysate | – | – | $9.42K | – |
By region
From the segment and revenue-disaggregation notes of Scientist Home Future Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.